Academic publisher SAGE has announced the launch of Translational Epigenomics, a new open access journal publishing research on epigenetic alterations in gene expression.
Translational Epigenomics will cover diverse aspects of this new and emergent field such as DNA methylation, posttranslational histone modifications, and non-mutational RNA regulatory mechanisms. The journal welcomes basic science and clinical medical specialty submissions.
Dr. Gaurang S. Daftary will serve as the journal’s Editor-In-Chief. Now open for submissions, Translational Epigenomics will focus on translational applicability and relevance of the research findings to health and disease.
